Seoul, South Korea, and Albuquerque, NM – August 9, 2022 – Deep Bio, a company concentrating on SaMD (Software as a Medical Device) for digital pathology, offering clinically validated, AI-based DeepDx® algorithms, and Indica Labs, a...

While it's long been understood that predicting outcomes in patients with cancer requires considering many factors, such as patient history, genes and disease pathology, clinicians struggle with integrating this information to make decisions...

Lumea, a leader in digital pathology solutions, has chosen Tempus, a leader in artificial intelligence and precision medicine, to create AI-enabled solutions LEHI, UTAH, UNITED STATES, August 4, 2022 /EINPresswire.com/ -- Lumea Inc, a leader...

Mindpeak breast cancer algorithms have been seamlessly integrated into the gold-standard image management software, CaloPix 5, enhancing the pathologist's possibilities. PARIS, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Tribun Health, the European...

Pathomation continues their series on software development. The earlier parts are available here: Part 1: Processes to facilitate a software development life cycle Part 2: The need for software validation In this episode, we want...

July 28, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), for patients with multiple architectural distortion (AD) identified on digital breast tomosynthesis (DBT), biopsy of all areas may be warranted, given...